Heart disease is a major health burden. Dyslipidaemia (abnormal levels of blood lipids- such as cholesterol) promotes the disease. We propose that one way by which lipids may do so is by rewiring the immune system, causing key cells (monocytes) to be switched ‘on’ to an inflammatory state. In this study we will be assessing whether, and how, this rewiring occurs.
What’s involved?
If you are chosen to take part in the study you will:
You may be eligible to participate in this study if:
If you are interested in assisting with this important and exciting area of research, please contact: Rana Baraz by email: Rana.Baraz@health.nsw.gov.au